CHNA Loncar China BioPharma ETF
What is CHNA?
CHNA tracks a tier-weighted index of companies directly involved in the growth of China’s pharmaceutical and biotech industry.
CHNA Factset Analytics Insight
CHNA targets China’s pharmaceutical and biotech (biopharma) sector. The fund includes pharmaceutical companies, biotech companies, drug manufacturers, diagnostics companies, wholesalers or distributors of biopharma products, and biopharma service providers. It is worth noting that manufacturers of pharmaceutical ingredients are excluded, as the fund focuses on innovation in the sector. CHNA uses a tiered weighting system. Starting from equal weight, all qualified constituents are assigned a weight adjustment based on market cap. Large cap stocks get a 140% adjustment, midcaps 100%, and small-caps 70%. The index is reconstituted on every second Monday of each February and August.
CHNA Summary Data
CHNA Portfolio Data
CHNA Index Data
CHNA Portfolio Management
CHNA Tax Exposures
CHNA Fund Structure
Factset Analytics Block Liquidity
This measurement shows how easy it is to trade a $1 million USD block of CHNA. CHNA is rated a 1 out of 5.
CHNA Sector/Industry Breakdown
CHNA Top 10 Holdings
CHNA Performance Statistics
CHNA Economic Development
CHNA Benchmark Comparison Summary
CHNA Benchmark Comparison Market Cap Size